SEC Company Response from EUDA Health Holdings Ltd (EUDA, EUDAW) (CIK 0001847846) (EUDA) — Sep 11, 2025
EUDA Health Holdings Ltd (EUDA, EUDAW) (CIK 0001847846)
Date: Sept. 11, 2025 · CIK: 0001847846 · Accession: 0001493152-25-013080
AI Filing Summary & Sentiment
File numbers found in text: 001-40678
Referenced dates: August 29, 2025
Show Raw Text
CORRESP
1
filename1.htm
EUDA
Health Holdings Ltd
60
Kaki Bukit Place, #03-01
Eunos
Techpark, Singapore 415979
September
11, 2025
Via
Edgar
United
States Securities and Exchange Commission
Division
of Corporation Finance Office
of
Industrial Applications and Services
Washington,
DC 20549
Attention:
Tayyaba Shafique and Terence O’Brien
Re:
EUDA
Health Holdings Ltd
Form
20-F for Fiscal Year Ended December 31, 2024
File
No. 001-40678
Dear
Tayyaba Shafique and Terence O’Brien:
We
hereby provide a response to the comment issued in a letter dated August 29, 2025 (the “Staff’s Letter”) regarding
the Company’s Form 20-F for Fiscal Year Ended December 31, 2024 (the “Form 20-F”). Contemporaneously, we are
filing Amendment No. 1 to the Form 20-F via Edgar (the “Form 20-F Amendment No. 1”).
For
ease of reference, the comment contained in the Staff’s Letter is reproduced below and is followed by the Company’s response.
All page references in the responses set forth below refer to the page numbers in the Form 20-F Amendment No. 1.
Form
20-F filed April 29, 2025
Report
of Independent Registered Public Accounting Firm, page F-1
1. Based
on the language provided in the audit reports of your successor and predecessor auditors,
it is not clear who has taken audit responsibility for the adjustments made to the prior
periods presented in the financial statements stemming from the changes to your reportable
segment structure. Please clarify whether J&S Associate PLT performed additional procedures
for the prior period segment changes and, if so, how they concluded they were not required
to revise their audit report to discuss the procedures performed on the prior period financial
statements. Refer to AS 3105 and Question 5 of the PCAOB’s Staff Questions and Answers
on Adjustments to Prior Period Financial Statements Audited by a Predecessor Auditor.
Response:
We respectfully advise the Staff that J&S Associate PLT, our successor auditor, has performed the necessary additional procedures
with respect to the retrospective adjustments related to our changes in reportable segment structure. In accordance with the guidance
in AS 3105 and Question 5 of the PCAOB’s Staff Questions and Answers on Adjustments to Prior-Period Financial Statements Audited
by a Predecessor Auditor, J&S Associate PLT revised their auditor’s report to address these procedures.
Please
do not hesitate to contact me or Tahra Wright, Esq. of Loeb & Loeb LLP at (212) 407-4122 if you would like additional information
with respect to any of the foregoing. Thank you.
Sincerely,
/s/
Alfred Lim
Alfred
Lim
Chief
Executive Officer
cc:
Tahra
Wright, Esq. (Twright@loeb.com)
Jane
Tam, Esq. (JTam@loeb.com)
2